Business · 12/12/2017
FDA Releases Guidance on Product Name Placement in Promotional Labeling and Advertisements
The Food and Drug Administration has finalized a guidance for industry on product name placement, size, and prominence in promotional labeling and advertisements for human and animal prescription drugs, following a 2013 draft guidance and a proposed collection of information for review under the Paperwork Reduction Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →